Germany's Draegerwerk H1 revenue rises, raises EBIT margin outlook
Germany's Draegerwerk H1 revenue rises, raises EBIT margin outlook
Overview
Germany medical and safety tech firm's H1 net sales rose 6% yr/yr
EBIT more than tripled, aided by strong operations and customs refund
Company raised 2026 EBIT margin forecast after receiving customs refunds
Outlook
Drägerwerk expects 2026 net sales to rise 2.0-6.0% net of currency effects
Company raises 2026 EBIT margin forecast to 6.0-8.0% from 5.0-7.5%
Drägerwerk sees further customs refunds possible but timing and amount are uncertain
Result Drivers
DIVISIONAL SALES GROWTH - Co said strong net sales growth in both medical and safety divisions drove results, with Americas and EMEA regions performing particularly well
GROSS MARGIN IMPROVEMENT - Co attributed higher earnings to improved gross margin in both divisions
CUSTOMS REFUND - One-off effect from U.S. customs reimbursement contributed to higher EBIT
Company press release: ID:nEQ89j7mMa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Sales |
| EUR 1.60 bln |
|
H1 EBIT |
| EUR 63.80 mln |
|
H1 EBIT Margin |
| 4.00% |
|
H1 Orders |
| EUR 1.75 bln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Draegerwerk AG & Co KGaA is €98.00, about 28.9% above its July 29 closing price of €76.00
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago
Reuters Recommended Reads
July 27 - Netherlands' Philips lifts annual profit, cash flow outlook after US tariff refund
July 29 - GE HealthCare tops quarterly estimates, weighs patient care unit sale
July 29 - German medical packaging firm Gerresheimer to sell two units to Apax for $1.71 billion
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)